InnoCan Pharma Reports Impressive Preclinical Trial Results as it Eyes Expansion into $52b Veterinary Services Industry
InnoCan Pharma Corporation, an Israeli pharmaceutical technology company and pioneer in CBD-Pharma delivery systems, reported positive results in a preclinical trial on epileptic seizures in dogs using LPT. The company is conducting this research in collaboration with Yissum, the commercial arm of The Hebrew University of Jerusalem.
Read full storyMeaTech 3D is developing cultured meat to take customized food to the next level
An investment in the future of food ― meet the company that is going to enable the production of real delicious, nutritious meat that’s slaughter-free. MeaTech 3D (Nasdaq: MITC) is a global deep-tech food company developing the advanced biotechnology and engineering capabilities to produce delicious, nutritious real meat made from cells rather than slaughtered animals. The company has been advancing its bio-printing technology in order to circumvent unsustainable challenges faced by conventional animal husbandry, such as the industry’s enormous carbon footprint, water and land usage, and animal welfare issues. Importantly, MeaTech has just made an announcement confirming a significant upgrade to its technology that should help the company continue accelerating its progress toward commercialization.
Read full story